Dongni Lin

机构：Shanghai Jiao Tong University, Renji Hospital, Kingmed Diagnostics, Guangzhou Medical University

发表论文 17 篇 · 总被引 209 次 · h-index 8

代表论文

• Preclinical efficacy and safety of encapsulated proliferating human hepatocyte organoids in treating liver failure (2024 · Cell stem cell · 被引 70)
• Preoperative administration of a biomimetic platelet nanodrug enhances postoperative drug delivery by bypassing thrombus (2023 · International Journal of Pharmaceutics · 被引 25)
• Scalable Preparation of Cylindrical Block Copolymer Micelles with a Liquid-Crystalline Perfluorinated Core by Photoinitiated Reversible Addition-Fragmentation Chain Transfer Dispersion Polymerization (2023 · Macromolecules · 被引 23)
• One‐Step Preparation of Thermo‐Responsive Poly( N ‐isopropylacrylamide)‐Based Block Copolymer Nanoparticles by Aqueous Photoinitiated Polymerization‐Induced Self‐Assembly (2021 · Macromolecular Rapid Communications · 被引 19)
• In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial (2026 · Nature Medicine · 被引 18)
• Promotion of NAD+ recycling by the hypoxia-induced shift in the lactate dehydrogenase isozyme profile reduces the senescence of human bone marrow-derived endothelial progenitor cells (2023 · Free Radical Biology and Medicine · 被引 17)